Evidence for etiologic field changes in tongue distant from tumor in patients with squamous cell carcinoma of the oral tongue
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
36314576
PubMed Central
PMC10108103
DOI
10.1002/path.6025
Knihovny.cz E-zdroje
- Klíčová slova
- CNV, SCCOT, SNV, chromosome 8, field cancerization,
- MeSH
- jazyk patologie MeSH
- lidé MeSH
- nádory jazyka * genetika MeSH
- nádory úst * patologie MeSH
- spinocelulární karcinom * patologie MeSH
- variabilita počtu kopií segmentů DNA MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Oral cancer is a paradigm of Slaughter's concept of field cancerization, where tumors are thought to originate within an area of cells containing genetic alterations that predispose to cancer development. The field size is unclear but may represent a large area of tissue, and the origin of mutations is also unclear. Here, we analyzed whole exome and transcriptome features in contralateral tumor-distal tongue (i.e. distant from the tumor, not tumor-adjacent) and corresponding tumor tissues of 15 patients with squamous cell carcinoma of the oral tongue. The number of point mutations ranged from 41 to 237 in tumors and from one to 78 in tumor-distal samples. Tumor-distal samples showed mainly clock-like (associated with aging) or tobacco smoking mutational signatures. Tumors additionally showed mutations that associate with cytidine deaminase AID/APOBEC enzyme activities or a UV-like signature. Importantly, no point mutations were shared between a tumor and the matched tumor-distal sample in any patient. TP53 was the most frequently mutated gene in tumors (67%), whereas a TP53 mutation was detected in only one tumor-distal sample, and this mutation was not shared with the matched tumor. Arm-level copy number variation (CNV) was found in 12 tumors, with loss of chromosome (Chr) 8p or gain of 8q being the most frequent events. Two tumor-distal samples showed a gain of Chr8, which was associated with increased expression of Chr8-located genes in these samples, although gene ontology did not show a role for these genes in oncogenic processes. In situ hybridization revealed a mixed pattern of Chr8 gain and neutral copy number in both tumor cells and adjacent nontumor epithelium in one patient. We conclude that distant field cancerization exists but does not present as tumor-related mutational events. The data are compatible with etiologic field effects, rather than classical monoclonal field cancerization theory. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Clinical Genetics Laboratory Medicine Norrlands Universitetssjukhus Umeå Sweden
Department of Clinical Sciences ENT Umeå University Umeå Sweden
Department of Medical Biosciences Pathology Umeå University Umeå Sweden
Research Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Zobrazit více v PubMed
Johnson DE, Burtness B, Leemans CR, PubMed PMC
Bray F, Ferlay J, Soerjomataram I, PubMed
Chow LQM. Head and neck cancer. N Engl J Med 2020; 382: 60–72. PubMed
Seiwert TY, Zuo Z, Keck MK, PubMed PMC
Rautava J, Luukkaa M, Heikinheimo K, PubMed
Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990; 160: 405–409. PubMed
Ziober AF, Patel KR, Alawi F, PubMed
Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007; 26: 645–662. PubMed
Ng JH, Iyer NG, Tan MH, PubMed
Deneuve S, Pérol O, Dantony E, PubMed
Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963–968. PubMed
Tabor MP, Brakenhoff RH, Ruijter‐Schippers HJ, PubMed PMC
Braakhuis BJ, Tabor MP, Kummer JA, PubMed
Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9–22. PubMed
Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer 2018; 18: 19–32. PubMed
Wu P, Xie C, Yang L, PubMed PMC
Lochhead P, Chan AT, Nishihara R, PubMed PMC
Dotto GP. Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J Clin Invest 2014; 124: 1446–1453. PubMed PMC
Gadaleta E, Thorn GJ, Ross‐Adams H, PubMed PMC
Jakubek YA, Chang K, Sivakumar S, PubMed PMC
Aran D, Camarda R, Odegaard J, PubMed PMC
Boldrup L, Gu X, Coates PJ, PubMed PMC
Cibulskis K, Lawrence MS, Carter SL, PubMed PMC
Van der Auwera GA, O'connor BD. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (1st edn). O'Reilly Media, 2020.
Lee J, Lee AJ, Lee JK, PubMed PMC
McKenna A, Hanna M, Banks E, PubMed PMC
Franch‐Exposito S, Bassaganyas L, Vila‐Casadesús M, PubMed PMC
Chen X, Chang CW, Spoerke JM, PubMed
Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods 2015; 12: 357–360. PubMed PMC
Pertea M, Pertea GM, Antonescu CM, PubMed PMC
Li B, Dewey CN. RSEM: accurate transcript quantification from RNA‐Seq data with or without a reference genome. BMC Bioinformatics 2011; 12: 323. PubMed PMC
Wang J, Vasaikar S, Shi Z, PubMed PMC
Huson DH, Beier S, Flade I, PubMed PMC
Cancer Genome Atlas Network . Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015; 517: 576–582. PubMed PMC
Califano J, van der Riet P, Westra W, PubMed
Martincorena I, Roshan A, Gerstung M, PubMed PMC
Yoshida K, Gowers KHC, Lee‐Six H, PubMed PMC
Lee‐Six H, Olafsson S, Ellis P, PubMed
Wijewardhane N, Dressler L, Ciccarelli FD. Normal somatic mutations in cancer transformation. Cancer Cell 2021; 39: 125–129. PubMed
Yokoyama A, Kakiuchi N, Yoshizato T, PubMed
Lawson ARJ, Abascal F, Coorens THH, PubMed
Colom B, Herms A, Hall MWJ, PubMed PMC
Ghosh A, Das C, Ghose S, PubMed PMC
Luginbuhl AJ, South AP. Understanding precancerous lesions of the oral cavity. J Pathol 2022: 103–105. PubMed PMC
Petljak M, Maciejowski J. Molecular origins of APOBEC‐associated mutations in cancer. DNA Repair 2020; 94: 102905. PubMed PMC
Cho RJ, Alexandrov LB, den Breems NY, PubMed
Kanu N, Cerone MA, Goh G, PubMed PMC
Venkatesan S, Angelova M, Puttick C, PubMed PMC
Baker SC, Mason AS, Southgate J. Procarcinogen activation and mutational signatures model the initiation of carcinogenesis in human urothelial tissues In vitro. Eur Urol 2020; 78: 143–147. PubMed PMC
Hölzl‐Armstrong L, Kucab JE, Moody S, PubMed PMC
Hölzl‐Armstrong L, Moody S, Kucab JE, PubMed
He Y, Rivera J, Diossy M, PubMed PMC
Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer 2018; 18: 269–282. PubMed
Veeramachaneni R, Walker T, Revil T, PubMed PMC
Shukla A, Nguyen THM, Moka SB, PubMed PMC
Wood HM, Conway C, Daly C, PubMed
Jolly C, Van Loo P. Timing somatic events in the evolution of cancer. Genome Biol 2018; 19: 95. PubMed PMC
Cerami E, Gao J, Dogrusoz U, PubMed PMC
Gao J, Aksoy BA, Dogrusoz U, PubMed PMC
Yasaei H, Gilham E, Pickles JC, PubMed